PSK Pharma Recognized with an Award from the Scientific Center for Expert Evaluation of Drug Products of the Russian Ministry of Health
At the plenary session of the scientific and practical conference “Regulatory Practice and Drug Registration – RegLek 2025”, chaired by Acting General Director of the Federal State Budgetary Institution “Scientific Center for Expert Evaluation of Medicinal Products” (FSBI “SCEEMP”) of the Russian Ministry of Health, Valentina Kosenko, PSK Pharma was honored with a diploma and the iconic RegLek “award bear” for a strong start in the category “Knowledge Is Light, Ignorance Leads to Expert Inquiries.”
Employees of the company actively participate in training programs organized by the Ministry of Health of the Russian Federation to enhance their professional qualifications. This year, PSK Pharma succeeded in arranging targeted training exclusively for its employees on the most relevant topics in drug development and regulatory registration. This format makes it possible to train a large team simultaneously while focusing on aspects most critical to PSK Pharma’s current portfolio.
This is especially important given the significant number of employees involved in drug development and registration and the impressive volume of ongoing projects. The ability to customize the training program and address specific, practical questions enables the company to work efficiently and bring in-demand, high-tech medicines to the market more quickly.
Evgenia Shapiro, General Director of PSK Pharma:
“With every passing year, our portfolio includes more and more complex pharmaceuticals, including a substantial segment of biotechnological products. The importance and value of such training cannot be overstated, as interacting with the leading experts of the Ministry of Health gives us the opportunity to receive essential and up-to-date knowledge directly from the source. We immediately apply these insights in practice during the development and registration of our medicines.
This intelligent approach enables PSK Pharma to conduct research and product characterization competently and optimally, fully aligned with modern requirements for quality, efficacy, and safety. For the regulator, this means receiving well-prepared dossiers for expert evaluation. We sincerely thank Valentina Kosenko for this unique opportunity and the unprecedented experience we gained during the training. We look forward to continuing our collaboration with the training center of FSBI SCEEMP of the Ministry of Health of Russia. A few years ago, the Ministry introduced a wonderful and motivating tradition of recognizing outstanding company teams, and we are truly pleased to receive both the diploma and the award bear.”
The RegLek conference traditionally brings together professionals from the pharmaceutical industry to discuss current domestic and international regulatory procedures, as well as new challenges. The event is attended by government officials, leading specialists from relevant agencies, and representatives of major businesses.
